ALZAMEND NEURO, INC. Other Income and Expense
ALZAMEND NEURO, INC. (ALZN) reported Other Income and Expense of -$1.61 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-10.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-09-10
- ALZAMEND NEURO, INC. nonoperating income (expense) for the quarter ending 2026-07-31 was -$1.61K.
- ALZAMEND NEURO, INC. nonoperating income (expense) for the quarter ending 2026-04-30 was $928.00.
- ALZAMEND NEURO, INC. nonoperating income (expense) for the quarter ending 2026-01-31 was -$1.34K.
- ALZAMEND NEURO, INC. nonoperating income (expense) for the quarter ending 2025-10-31 was -$2.65K.
- ALZAMEND NEURO, INC. nonoperating income (expense) for fiscal 2026 was -$5.54K.
- ALZAMEND NEURO, INC. nonoperating income (expense) for fiscal 2025 was -$18.03K.
- ALZAMEND NEURO, INC. nonoperating income (expense) for fiscal 2024 was -$10.10K.
- ALZAMEND NEURO, INC. nonoperating income (expense) for fiscal 2023 was -$7.70K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$1.61K 10-Q · filed 2026-09-10 | -$678.00 derived: sum of 2 quarters · filed 2026-09-10 | -$2.02K derived: sum of 3 quarters · filed 2026-09-10 | -$4.66K derived: sum of 4 quarters · filed 2026-09-10 |
| 2026-04-30 | $928.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-22 | -$409.00 derived: sum of 2 quarters · filed 2026-07-22 | -$3.06K derived: sum of 3 quarters · filed 2026-07-22 | -$5.54K 10-K · filed 2026-07-22 |
| 2026-01-31 | -$1.34K 10-Q · filed 2026-03-11 | -$3.99K derived: sum of 2 quarters · filed 2026-03-11 | -$6.47K 10-Q · filed 2026-03-11 | -$6.98K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-10-31 | -$2.65K 10-Q · filed 2025-12-09 | -$5.13K 10-Q · filed 2025-12-09 | -$5.64K derived: sum of 3 quarters · filed 2026-09-10 | -$7.66K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-07-31 | -$2.48K 10-Q · filed 2026-09-10 | -$2.99K derived: sum of 2 quarters · filed 2026-09-10 | -$5.01K derived: sum of 3 quarters · filed 2026-09-10 | -$8.51K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-04-30 | -$509.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-22 | -$2.53K derived: sum of 2 quarters · filed 2026-07-22 | -$6.02K derived: sum of 3 quarters · filed 2026-07-22 | -$18.03K 10-K · filed 2026-07-22 |
| 2025-01-31 | -$2.02K 10-Q · filed 2026-03-11 | -$5.51K derived: sum of 2 quarters · filed 2026-03-11 | -$17.52K 10-Q · filed 2026-03-11 | -$18.98K derived: sum of 4 quarters · filed 2026-03-11 |
| 2024-10-31 | -$3.50K 10-Q · filed 2025-12-09 | -$15.50K 10-Q · filed 2025-12-09 | -$16.97K derived: sum of 3 quarters · filed 2025-12-09 | -$19.45K derived: sum of 4 quarters · filed 2025-12-09 |
| 2024-07-31 | -$12.01K 10-Q · filed 2025-09-10 | -$13.47K derived: sum of 2 quarters · filed 2025-09-10 | -$15.96K derived: sum of 3 quarters · filed 2025-09-10 | -$20.27K derived: sum of 4 quarters · filed 2025-09-10 |
| 2024-04-30 | -$1.47K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-22 | -$3.95K derived: sum of 2 quarters · filed 2025-07-22 | -$8.26K derived: sum of 3 quarters · filed 2025-07-22 | -$10.10K 10-K · filed 2025-07-22 |
| 2024-01-31 | -$2.49K 10-Q · filed 2025-03-10 | -$6.80K derived: sum of 2 quarters · filed 2025-03-10 | -$8.64K 10-Q · filed 2025-03-10 | -$9.15K derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-10-31 | -$4.31K 10-Q · filed 2024-12-11 | -$6.15K 10-Q · filed 2024-12-11 | -$6.67K derived: sum of 3 quarters · filed 2024-12-11 | -$8.73K derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-07-31 | -$1.83K 10-Q · filed 2024-09-11 | -$2.35K derived: sum of 2 quarters · filed 2024-09-11 | -$4.42K derived: sum of 3 quarters · filed 2024-09-11 | -$8.00K derived: sum of 4 quarters · filed 2024-09-11 |
| 2023-04-30 | -$519.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$2.58K derived: sum of 2 quarters · filed 2024-07-30 | -$6.17K derived: sum of 3 quarters · filed 2024-07-30 | -$7.70K 10-K · filed 2024-07-30 |
| 2023-01-31 | -$2.06K 10-Q · filed 2024-03-25 | -$5.65K derived: sum of 2 quarters · filed 2024-03-25 | -$7.18K 10-Q · filed 2024-03-25 | -$3.78K derived: sum of 4 quarters · filed 2024-03-25 |
| 2022-10-31 | -$3.59K 10-Q · filed 2023-12-15 | -$5.12K 10-Q · filed 2023-12-15 | -$1.72K derived: sum of 3 quarters · filed 2023-12-15 | -$18.02K derived: sum of 4 quarters · filed 2023-12-15 |
| 2022-07-31 | -$1.53K 10-Q · filed 2023-09-13 | $1.87K derived: sum of 2 quarters · filed 2023-09-13 | -$14.43K derived: sum of 3 quarters · filed 2023-09-13 | -$30.43K derived: sum of 4 quarters · filed 2023-09-13 |
| 2022-04-30 | $3.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-27 | -$12.90K derived: sum of 2 quarters · filed 2023-07-27 | -$28.90K derived: sum of 3 quarters · filed 2023-07-27 | -$42.52K 10-K · filed 2023-07-27 |
| 2022-01-31 | -$16.30K 10-Q · filed 2023-03-15 | -$32.29K derived: sum of 2 quarters · filed 2023-03-15 | -$45.92K 10-Q · filed 2023-03-15 | -$82.78K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-10-31 | -$15.99K 10-Q · filed 2022-12-12 | -$29.62K 10-Q · filed 2022-12-12 | -$66.48K derived: sum of 3 quarters · filed 2022-12-12 | -$69.70K derived: sum of 4 quarters · filed 2022-12-12 |
| 2021-07-31 | -$13.63K 10-Q · filed 2022-09-13 | -$50.48K derived: sum of 2 quarters · filed 2022-09-13 | -$53.71K derived: sum of 3 quarters · filed 2022-09-13 | -$109.86K derived: sum of 4 quarters · filed 2022-09-13 |
| 2021-04-30 | -$36.86K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-19 | -$40.08K derived: sum of 2 quarters · filed 2022-07-19 | -$96.23K derived: sum of 3 quarters · filed 2022-07-19 | -$94.68K 10-K · filed 2022-07-19 |
| 2021-01-31 | -$3.23K 10-Q · filed 2022-03-15 | -$59.38K derived: sum of 2 quarters · filed 2022-03-15 | -$57.82K 10-Q · filed 2022-03-15 | |
| 2020-10-31 | -$56.15K 10-Q · filed 2021-12-13 | -$54.60K 10-Q · filed 2021-12-13 | ||
| 2020-07-31 | $1.55K 10-Q · filed 2021-09-13 | |||
| 2020-04-30 | $13.93K 10-K · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |